Chemical Structure (Exemestane 01)
Exemestane Tablet, Film Coated
Product Images NDC 51991-005
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Exemestane (NDC 51991-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Breckenridge Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Exemestane 02)
This is a statistical report on the disease-free survival of patients treated with either Exemestane or Tamoxifen. The report includes the proportion surviving, hazard ratio (HR), and p-value obtained from log-rank analysis. It also shows the number of patients randomized for each treatment and the duration of disease-free survival in months. The text also contains some unidentifiable characters, but they do not affect the overall understanding of the report.*
Figure 2 (Exemestane 03)
Not available.*
Principal Display Panel (25 mg Tablet Bottle Label)
This appears to be a product label for Exemestane Tablets containing 25mg. It includes a National Drug Code (NDC) number and a GTIN code. The lot number is also provided, with an associated expiration date. It mentions that the information will be coded in 2D during packing.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
